THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Naoko Takebe to Mechanistic Target of Rapamycin Complex 2

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Mechanistic Target of Rapamycin Complex 2.
Naoko Takebe
Connection Strength
0.242
Mechanistic Target of Rapamycin Complex 2
  1. A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2025 Feb 25; 95(1):37.
    View in: PubMed
    Score: 0.242
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES